| abstract |
The invention describes the piperidyl and the piperazinyl carbamide compound of some heteroaryl-replacement, described chemical compound can be used as the FAAH inhibitor.This chemical compound can use in being used for the treatment of by the pharmaceutical composition of the active disease states mediated of fatty acid amide hydrolase (FAAH), obstacle and disease and method, and described morbid state, obstacle and disease for example are anxiety, pain, inflammation, sleep disorder, eating disorders, insulin resistant, diabetes, osteoporosis and moving disorder (as multiple sclerosis). |